Skip to main content
Midas Edge

NORTHWEST BIOTHERAPEUTICS INC

For the period ended Jun 30, 2026. Filed Aug 14, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 14, 2026

NWBO$0.19-0.6%Stored close · as of Jun 30, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

​​​
PART I - FINANCIAL INFORMATION3
​​​
Item 1.Condensed Consolidated Interim Financial Statements (Unaudited)​
​​
​Condensed Consolidated Balance Sheets as of June 30, 2026 and December 31, 20253
​​
​Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2026 and 20254
​​
​Condensed Consolidated Statements of Stockholders’ Deficit for the three and six months ended June 30, 2026 and 20255
​​
​Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2026 and 20257
​​
​Notes to Condensed Consolidated Financial Statements9
​​​
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations23
​
Item 3.Quantitative and Qualitative Disclosures About Market Risk28
​
Item 4.Controls and Procedures29
​​​
PART II - OTHER INFORMATION30
​​​
Item 1.Legal Proceedings30
​
Item 1A.Risk Factors31
​
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds31
​
Item 3.Defaults Upon Senior Securities31
​
Item 4.Mine Safety Disclosures31
​​
Item 5.Other Information31
​
Item 6.Exhibits31
​​​
SIGNATURES32
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.